Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence. (Q42256566)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Danae Papadogianni

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nikolaos Soulitzis

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Demetrios Delakas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

11 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

2481-2489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24213852%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Bladder cancer: epidemiology, staging and grading, and diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Urothelial tumorigenesis: a tale of divergent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

TP53 family members and human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

The isoforms of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Loss of p63 expression is associated with tumor progression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Accumulation of nuclear p53 and tumor progression in bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Meta-analysis of age-related gene expression profiles identifies common signatures of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

p53: guardian of the genome and policeman of the oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1328-4

Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

21 January 2018

1 reference

12 December 2020

Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection

1 reference

12 December 2020

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder

1 reference

12 December 2020

Evolution of functions within the p53/p63/p73 family.

1 reference

12 December 2020

Overexpression of the wild type p73 gene in human bladder cancer

1 reference

12 December 2020

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

12 December 2020

Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer

1 reference

12 December 2020

Differential regulation of p63 and p73 expression

1 reference

12 December 2020

Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods

1 reference

12 December 2020

The Role of p63 and p73 in tumor formation and progression: coming of age toward clinical usefulness. Commentary re: F. Koga et al., Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma

1 reference

12 December 2020

The fibroblast growth factor receptor 3 (FGFR3) mutation is a strong indicator of superficial bladder cancer with low recurrence rate

1 reference

12 December 2020

p73 Expression in human normal and tumor tissues: loss of p73alpha expression is associated with tumor progression in bladder cancer.

1 reference

12 December 2020

Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.

1 reference

12 December 2020

p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma

1 reference

12 December 2020

Assessment of the transcriptional activity of p53 improves the prediction of recurrence in superficial transitional cell carcinoma of the bladder

1 reference

12 December 2020